Korean J Med Mycol.  2005 Mar;10(1):1-10.

Systemic Antifungal Agents and Clinical Application

Affiliations
  • 1Division of Infectious Disease, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea. junheewoo@amc.seoul.kr r

Abstract

In the past, even two decades ago, it was not easy for the physicians to diagnose the systemic fungal infection especially in immuno-compromised host. However, as malignant neoplasm and organ transplantation increased, the incidence of fungal infection became heightened. Also the development of newer technique of microbiology and computerized imaging methods made it relatively easy to diagnose the fungal infection. Several new antifungal agents developed recently. It is necessary for us to prescribe the antifungal agents optimally. We summarized amphotericin B lipid formulations, newer triazoles, echinocandins.

Keyword

Liposomal amphotericin B; Voriconazole; Caspofungin

MeSH Terms

Amphotericin B
Antifungal Agents*
Echinocandins
Incidence
Organ Transplantation
Transplants
Triazoles
Amphotericin B
Antifungal Agents
Echinocandins
Triazoles
Full Text Links
  • KJMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr